2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Postmenopausal: new trials by email Literature Review of Postmenopausal trials Research Report on Postmenopausal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of HLX14 vs. Denosumab Prolia® in Postmenopausal Women With Osteoporosis at High Risk of Fracture HLX14, Prolia® - Postmenopausal | Phase 3 | Completed | Shanghai Henlius Biotech | 514 | 2022-06-17 | 2024-09-20 |
| Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer Letrozole, Zoledronic acid - Osteoporosis, Postmenopausal | Phase 3 | Completed | Novartis | 83 | 2006-01-01 | 2011-11-16 |
Breast Neoplasms (1) · Osteoporosis (1)
Bone Diseases (1) · Bone Diseases, Metabolic (1) · Breast Diseases (1) · Metabolic Diseases (1) · Musculoskeletal Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Nutritional and Metabolic Diseases (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Denosumab (1) · Letrozole (1) · Zoledronic Acid (1)
Novartis (1) · Shanghai Henlius Biotech (1)
China (1) · Germany (1)